Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors
| Image |  |
|---|---|
| Description | scientific article published on 15 February 2020 |
| Author/s |
author: Razelle Kurzrock Anthony W Tolcher |
| Publication date | February 15, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |